Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 2129-2131

  Hahn, Paul ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aflibercept; Anti VEGF; Neovascular age related macular degeneration; Vitrectomized

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; VASCULOTROPIN;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CASE REPORT; CATARACT EXTRACTION; DISEASE COURSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MEDICAL HISTORY; METAMORPHOSIS; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA TRANSLOCATION; SINGLE DRUG DOSE; STRABISMUS SURGERY; SUBRETINAL NEOVASCULARIZATION; VERY ELDERLY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY;

EID: 84908307121     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S73265     Document Type: Article

References (6)

1. Yanyali A, Aytug B, Horozoglu F, Nohutcu AF. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol. 2007;144(1):124–126.
2. Stewart MW, Rosenfeld PJ, Penha FM, et al. Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye). Retina. 2012;32(3):434–457.
3. Boyer DS, Faber D, Gupta S, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011;31(5):915–923.
4. Reibaldi M, Russo A, Zagari M, et al. Resolution of persistent cystoid macular edema due to central retinal vein occlusion in a vitrectomized eye following intravitreal implant of dexamethasone 0.7 mg. Case Rep Ophthalmol. 2012;3(1):30–34.
5. Adán A, Pelegrín L, Rey A, et al. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 2013;33(7):1435–1440.
6. Grewal DS, Gill MK, Sarezky D, Lyon AT, Mirza RG. Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results. Eye (Lond). 2014;28(7):895–899.